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.2012.05.0Abstract A good number of abstracts and research articles (in total 74) published, so far, for
evaluating antioxidant activity of various samples of research interest were gone through where
407 methods were come across, which were repeated from 29 different methods. These were classiﬁed
as in vitro and in vivomethods. And those are described and discussed below in this review article. In
the later part of this review article, frequency of in vitro as well as in vivo methods is analyzed with a
bar diagram. Solvents are important for extracting antioxidants from natural sources. Frequency of
solvents used for extraction is also portrayed and the results are discussed in this article. As per this
review there are 19 in vitro methods and 10 in vivo methods that are being used for the evaluation of
antioxidant activity of the sample of interest. DPPH method was found to be used mostly for the
in vitro antioxidant activity evaluation purpose while LPO was found as mostly used in vivo antiox-
idant assay. Ethanol was with the highest frequency as solvent for extraction purpose.
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The human body has a complex system of natural enzymatic
and non-enzymatic antioxidant defenses which counteract
the harmful effects of free radicals and other oxidants. Free
radicals are responsible for causing a large number of diseases
including cancer (Kinnula and Crapo, 2004), cardiovascular
disease (Singh and Jialal, 2006), neural disorders (Sas et al.,
2007), Alzheimer’s disease (Smith et al., 2000), mild cognitive
impairment (Guidi et al., 2006), Parkinson’s disease (Bolton
et al., 2000), alcohol induced liver disease (Arteel, 2003), ulcer-
ative colitis (Ramakrishna et al., 1997), aging (Hyun et al.,
2006) and atherosclerosis (Upston et al., 2003). Protection
against free radicals can be enhanced by ample intake of die-
tary antioxidants. Substantial evidence indicates that foods
containing antioxidants and possibly in particular the antioxi-
dant nutrients may be of major importance in disease preven-
tion. There is, however, a growing consensus among scientists
that a combination of antioxidants, rather than single entities,
may be more effective over the long term. Antioxidants may be
of great beneﬁt in improving the quality of life by preventing
or postponing the onset of degenerative diseases. In addition,
they have a potential for substantial savings in the cost of
health care delivery.
Various methods are used to investigate the antioxidant
property of samples (diets, plant extracts, commercial antioxi-
dants etc.). The objective of this review article is to accumulateall probable methods that are used to evaluate the antioxidant
property of various samples. A compiled description of all
available in vitro and in vivo antioxidant models would provide
proliﬁc advantages to the researchers of this arena by reducing
their time for literature review and method development. Two
review articles have been published earlier (Chanda and Dave,
2009 and Badarinath et al., 2010) on in vitro evaluation of anti-
oxidant activity. In this article, attempts have been taken to
include in vivo too and to analyze the frequency of the use of
different methods.2. Methods
Internet browsing from Google Scholar database was used to
identify and to download abstracts and research papers related
to antioxidant activity study using suitable keywords (antioxi-
dant + plant extract + in vitro+ in vivo) in the month of
August 2011. In the ﬁrst thirty-four pages, a total of three hun-
dred and forty articles appeared and those were subjected to
preliminary screening. The basis of the selection of the articles
was (i) antioxidant activity of plant extracts and (ii) description
of antioxidant test procedures. A total of seventy-four papers
and abstracts were identiﬁed and reviewed for in vivo and
in vitro methods related to antioxidant evaluation. Solvents
used for extraction purpose are also reviewed from the
downloaded scientiﬁc records.
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Antioxidant activity should not be concluded based on a single
antioxidant test model. And in practice several in vitro test
procedures are carried out for evaluating antioxidant activities
with the samples of interest. Another aspect is that antioxidant
test models vary in different respects. Therefore, it is difﬁcult
to compare fully one method to other one. To some extent
comparison among different in vitro methods has been done
by Badarinath et al. (2010), while we discussed the methods
in terms of grouping in the present manuscript. Researcher
has to critically verify methods of analysis before adopting that
one for his/her research purpose. Generally in vitro antioxidant
tests using free radical traps are relatively straightforward to
perform. Among free radical scavenging methods, DPPH
method is furthermore rapid, simple (i.e. not involved with
many steps and reagents) and inexpensive in comparison to
other test models. On the other hand ABTS decolorization
assay is applicable for both hydrophilic and lipophilic antiox-
idants. In this article all in vitro methods are described and it is
important to note that one may optimize logically the respec-
tive method to serve his/her experimental objective as no one
method is absolute in nature rather than an example.
3.1. DPPH scavenging activity
The molecule 1, 1-diphenyl-2-picrylhydrazyl (a,a-diphenyl-b-
picrylhydrazyl; DPPH) is characterized as a stable free radical
by virtue of the delocalisation of the spare electron over the
molecule as a whole, so that the molecule does not dimerize,
as would be the case with most other free radicals. The delocal-
ization of electron also gives rise to the deep violet color, char-
acterized by an absorption band in ethanol solution centered
at about 517 nm. When a solution of DPPH is mixed with that
of a substrate (AH) that can donate a hydrogen atom, then this
gives rise to the reduced form with the loss of this violet color.In order to evaluate the antioxidant potential through free
radical scavenging by the test samples, the change in optical
density of DPPH radicals is monitored. According to Man-
zocco et al., 1998 the sample extract (0.2 mL) is diluted with
methanol and 2 mL of DPPH solution (0.5 mM) is added.
After 30 min, the absorbance is measured at 517 nm. The per-
centage of the DPPH radical scavenging is calculated using the
equation as given below:
% inhibition of DPPH radical ¼ ð½Abr  Aar=AbrÞ  100
where Abr is the absorbance before reaction and Aar is the
absorbance after reaction has taken place.
3.2. Hydrogen peroxide scavenging (H2O2) assay
Human beings are exposed to H2O2 indirectly via the environ-
ment nearly about 0.28 mg/kg/day with intake mostly fromleaf crops. Hydrogen peroxide may enter into the human body
through inhalation of vapor or mist and through eye or skin
contact. H2O2 is rapidly decomposed into oxygen and water
and this may produce hydroxyl radicals (OH) that can initiate
lipid peroxidation and cause DNA damage in the body.
The ability of plant extracts to scavenge hydrogen peroxide
can be estimated according to the method of Ruch et al. (1989).
A solution of hydrogen peroxide (40 mM) is prepared in phos-
phate buffer (50 mM pH 7.4). The concentration of hydrogen
peroxide is determined by absorption at 230 nm using a spec-
trophotometer. Extract (20–60 lg/mL) in distilled water is
added to hydrogen peroxide and absorbance at 230 nm is deter-
mined after 10 min against a blank solution containing phos-
phate buffer without hydrogen peroxide. The percentage of
hydrogen peroxide scavenging is calculated as follows:
% scavenged ðH2O2Þ ¼ ½ðAi  AtÞ=Ai  100
where Ai is the absorbance of control and At is the absorbance
of test.
3.3. Nitric oxide scavenging activity
NO is generated in biological tissues by speciﬁc nitric oxide
synthases, which metabolizes arginine to citrulline with the
formation of NO via a ﬁve electron oxidative reaction (David,
1999; Ghafourifar and Cadenas, 2005; Marletta, 1989;
Moncada et al., 1989; and Virginia et al., 2003). The com-
pound sodium nitroprusside is known to decompose in aque-
ous solution at physiological pH (7.2) producing NO. Under
aerobic conditions, NO reacts with oxygen to produce stable
products (nitrate and nitrite), the quantities of which can be
determined using Griess reagent (Marcocci et al., 1994). Two
(2) mL of 10 mM sodium nitroprusside dissolved in 0.5 mL
phosphate buffer saline (pH 7.4) is mixed with 0.5 mL of sam-
ple at various concentrations (0.2–0.8 mg/mL). The mixture is
then incubated at 25 C. After 150 min of incubation, 0.5 mLof the incubated solution is withdrawn and mixed with
0.5 mL of Griess reagent [(1.0 mL sulfanilic acid reagent
(0.33% in 20% glacial acetic acid at room temperature for
5 min with 1 mL of naphthylethylenediamine dichloride
(0.1% w/v)]. The mixture is then incubated at room tempera-
ture for 30 min and its absorbance pouring into a cuvette is
measured at 546 nm. The amount of nitric oxide radical inhi-
bition is calculated following this equation:
% inhibition of NO radical ¼ ½A0  A1=A0  100
where A0 is the absorbance before reaction and A1 is the absor-
bance after reaction has taken place with Griess reagent.
3.4. Peroxynitrite radical scavenging activity
Peroxynitrite (ONOO) is a cytotoxicant with strong oxidizing
properties toward various cellular constituents, including
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cell death, lipid peroxidation, carcinogenesis and aging. It is
generated in vivo by endothelial cells, Kupffer cells, neutrophils
and macrophages. Peroxynitrite radical is a relatively stable
species compared with other free radicals but once protonated
gives highly reactive peroxynitrous acid (ONOOH), decom-
posing with a very short half-life (1.9 s) at 37 C to form var-
ious cytotoxicants and that can induce the oxidation of thiol
(SH) groups on proteins, nitration of tyrosine, lipid peroxi-
dation and also nitrosation reactions, affecting cell metabolism
and signal transduction. It can ultimately contribute to cellular
and tissue injury with DNA strand breakage and apoptotic cell
death, e.g. in thymocytes, cortical cells and HL-60 leukemia
cells. Its excessive formation may also be involved in several
human diseases such as Alzheimer’s disease, rheumatoid
arthritis, cancer and atherosclerosis. Due to the lack of endog-
enous enzymes responsible for ONOO inactivation, develop-
ing speciﬁc ONOO scavengers is of considerable importance.
The method described by Kooy et al., 1994 involves the use
of a stock solution of dihydroxyrhodamine 123 (DHR 123,
5 mM) in dimethylformamide that is purged with nitrogen
and stored at 80 C. Working solution with DHR 123 (ﬁnal
concentration 5 lM) is diluted from the stock solution and is
placed on ice in the dark immediately prior to the experiment.
Buffer solution, 50 mM sodium phosphate (pH 7.4), contain-
ing 90 mM sodium chloride and 5 mM potassium chloride
with 100 lM diethylenetriaminepentaacetic acid (DTPA) are
purged with nitrogen and placed on ice before use. Scavenging
activity of ONOO by the oxidation of DHR 123 is measured
on a microplate ﬂuorescence spectrophotometer with excita-
tion and emission wavelengths of 485 nm and 530 nm at room
temperature, respectively. The background and ﬁnal ﬂuores-
cent intensities are measured 5 min after treatment without
3-morpholino- sydnonimine (SIN-1) or authentic (ONOO).
Oxidation of DHR 123 by decomposition of SIN-1 gradually
increased whereas authentic ONOO rapidly oxidized DHR
123 with its ﬁnal ﬂuorescent intensity being stable over time.3.5. Trolox equivalent antioxidant capacity (TEAC) method/
ABTS radical cation decolorization assay
This method, uses a diode-array spectrophotometer to mea-
sure the loss of color when an antioxidant is added to the
blue–green chromophore ABTSÆ + (2,2-azino-bis(3-ethylbenz-
thiazoline-6-sulfonic acid)). The antioxidant reduces ABTSÆ+
to ABTS and decolorize it. ABTSÆ+ is a stable radical not
found in the human body. Antioxidant activity can be mea-
sured as described by Seeram et al. (2006). ABTS radical cat-
ions are prepared by adding solid manganese dioxide (80 mg)
to a 5 mM aqueous stock solution of ABTS (20 mL using a
75 mM Na/K buffer of pH 7). Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), a water-soluble ana-
log of vitamin E, can be used as an antioxidant standard. A
standard calibration curve is constructed for Trolox at 0, 50,
100, 150, 200, 250, 300, and 350 lM concentrations. Samples
are diluted appropriately according to antioxidant activity in
Na/K buffer pH, 7. Diluted samples are mixed with 200 lL
of ABTS+ radical cation solution in 96-well plates, and
absorbance is read (at 750 nm) after 5 min in a microplate
reader. TEAC values can be calculated from the Trolox stan-
dard curve and expressed as Trolox equivalents (in mM).3.6. Total radical-trapping antioxidant parameter (TRAP)
method
This method is based on the protection provided by antioxi-
dants on the ﬂuorescence decay of R-phycoerythrin (R-PE)
during a controlled peroxidation reaction. The ﬂuorescence
of R-Phycoerythrin is quenched by ABAP (2,20-azo–bis(2-ami-
dino-propane)hydrochloride) as a radical generator. This
quenching reaction is measured in the presence of antioxi-
dants. The antioxidative potential is evaluated by measuring
the decay in decoloration. According to Ghiselli et al. (1995)
120 lL of diluted sample is added to 2.4 mL of phosphate buf-
fer (pH 7.4), 375 lL of bidistilled water, 30 lL of diluted R-PE
and 75 lL of ABAP; the reaction kinetics at 38 C is recorded
for 45 min by a luminescence spectrometer. TRAP values are
calculated from the length of the lag-phase due to the sample
compared with standard.
3.7. Ferric reducing-antioxidant power (FRAP) assay
This method measures the ability of antioxidants to reduce fer-
ric iron. It is based on the reduction of the complex of ferric
iron and 2,3,5-triphenyl-1,3,4-triaza-2-azoniacyclopenta-1,4-
diene chloride (TPTZ) to the ferrous form at low pH. This
reduction is monitored by measuring the change in absorption
at 593 nm, using a diode-array spectrophotometer. Antioxi-
dant assay can be conducted by the method developed by Ben-
zie and Strain (1999). Three milliliter of prepared FRAP
reagent is mixed with 100 lL of diluted sample; the absorbance
at 593 nm is recorded after a 30 min incubation at 37 C.
FRAP values can be obtained by comparing the absorption
change in the test mixture with those obtained from increasing
concentrations of Fe3+ and expressed as mM of Fe2+ equiv-
alents per kg (solid food) or per L (beverages) of sample.
3.8. Superoxide radical scavenging activity (SOD)
Although superoxide anion is a weak oxidant, it ultimately
produces powerful and dangerous hydroxyl radicals as well
as singlet oxygen, both of which contribute to oxidative stress
(Meyer and Isaksen, 1995). The superoxide anion scavenging
activity can be measured as described by Robak and
Gryglewski (1988). The superoxide anion radicals are gener-
ated in 3.0 mL of Tris–HCl buffer (16 mM, pH 8.0), contain-
ing 0.5 mL of nitroblue tetrazolium (NBT) (0.3 mM), 0.5 mL
NADH (0.936 mM) solution, 1.0 mL extract and 0.5 mL
Tris–HCl buffer (16 mM, pH 8.0). The reaction is initiated
by adding 0.5 mL phenazine methosulfate (PMS) solution
(0.12 mM) to the mixture, incubated at 25 C for 5 min and
then the absorbance is measured at 560 nm against a blank
sample.
3.9. Hydroxyl radical scavenging activity
Hydroxyl radical is one of the potent reactive oxygen species in
the biological system that reacts with polyunsaturated fatty
acid moieties of cell membrane phospholipids and causes dam-
age to cell. The scavenging ability of hydroxyl radicals is mea-
sured by the method of Kunchandy and Rao (1990). The
reaction mixture (1.0 mL) consist of 100 lL of 2-deoxy-
Dribose (28 mM in 20 mM KH2PO4-KOH buffer, pH 7.4),
500 lL of the extract, 200 lL EDTA (1.04 mM) and 200 lM
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acid (1.0 mM) which is incubated at 37 C for 1 h. One millili-
ter of thiobarbituric acid (1%) and 1.0 mL of trichloroacetic
acid (2.8%) are added and incubated at 100 C for 20 min.
After cooling, absorbance is measured at 532 nm, against a
blank sample.
3.10. Hydroxyl radical averting capacity (HORAC) method
The HORAC assay described by Ou et al. (2002) measures the
metal-chelating activity of antioxidants in the conditions of
Fenton-like reactions employing a Co (II) complex and hence
the protecting ability against formation of hydroxyl radical.
Hydrogen peroxide solution of 0.55 M is prepared in distilled
water and 4.6 mM Co (II) is prepared by dissolving 15.7 mg
of CoF2Æ4H2O and 20 mg of picolinic acid in 20 mL of distilled
water. Fluorescein – 170 lL (60 nM, ﬁnal concentration) and
10 lL of sample are incubated at 37 C for 10 min. directly
in the plate reader. After incubation 10 lL H2O2 (27.5 mM, ﬁ-
nal concentration) and 10 lL of Co (II) (230 lM ﬁnal concen-
tration) solutions are added subsequently. The initial
ﬂuorescence is measured after which the readings are taken
every min. after shaking. For the blank sample, phosphate buf-
fer solution is used. 100, 200, 600, 800 and 1000 lM standard
antioxidant solutions (in phosphate buffer 75 mM, pH 7.4) are
used for building the standard curve. The ﬁnal HORAC values
are calculated using a regression equation between the stan-
dard antioxidant concentration and the net area under the
curve. One HORAC unit is assigned to the net protection area
provided by 1 lM standard antioxidant and the activity of the
sample is expressed as lM standard antioxidant equivalents
per gram of fresh weight of the samples. Gallic acid can be
used as standard antioxidant.
3.11. Oxygen radical absorbance capacity (ORAC) Method
ORAC is an exciting and revolutionary new test tube analysis
that can be utilized to test ‘‘Antioxidant Power’’ of foods and
other chemical substances. This test can be done using either b-
phycoerythrin (b-PE) or ﬂuorescein as target molecule. While
reviewing, b-PE is not encountered in the publications later
than 2005. Thus it seems ﬂuorescein is replacing the b-PE as
target molecule in ORAC assay. The test is performed using
Trolox (a water-soluble analog of Vitamin E) as a standard
to determine the Trolox Equivalent (TE). The ORAC value
is then calculated from the Trolox Equivalent and expressed
as ORAC units or value. The higher the ORAC value, the
greater the ‘‘Antioxidant Power’’.
This assay is based on generation of free radical using
AAPH (2,2-azobis 2-amidopropane dihydrochloride) and
measurement of decrease in ﬂuorescence in the presence of free
radical scavengers. Prior et al. (2003) have reported an auto-
mated ORAC assay. In this assay b-phycoerythrin (b-PE)
was used as target free radical damage, AAPH as a peroxy rad-
ical generator and Trolox as a standard control. After addition
of AAPH to the test solution, the ﬂuorescence is recorded and
the antioxidant activity is expressed as trolox equivalent (Cao
et al., 1993; Frei et al., 1990).
The assay can be carried out according to Prior et al. (2003)
in 96-well polypropylene ﬂuorescence plates with a ﬁnal
volume of 200 lL. Assays are conducted at pH 7.0 with Trolox
(6.25, 12.5, 25, and 50 lmol/L for lipophilic assays; 12.5, 25, 50and 100 lmol/L hydrophilic assays) as the standard and
75 mM/L phosphate buffer as the blank. After the addition
of AAPH, the plate is placed immediately in a multilabel coun-
ter preheated to 37 C. The plate is shaken in an orbital man-
ner for 10 s and the ﬂuorescence is read at 1 min intervals for
35 min at the excitation wavelength of 485 nm and emission
wavelength of 520 nm. Area-under-the-curve is calculated for
each sample using Wallac Workout 1.5 software. Final compu-
tation of results is made by taking the difference of areas-un-
der-the-decay curves between blank and sample and/or
standard (Trolox) and expressing this in lM of Trolox equiv-
alents (TE) per g dry weight of sample (lM TE/g).
3.12. Reducing power method (RP)
This method is based on the principle of increase in the absor-
bance of the reaction mixtures. Increase in the absorbance
indicates an increase in the antioxidant activity. In this meth-
od, antioxidant compound forms a colored complex with
potassium ferricyanide, trichloro acetic acid and ferric chlo-
ride, which is measured at 700 nm. Increase in absorbance of
the reaction mixture indicates the reducing power of the sam-
ples (Jayaprakash et al., 2001). In the method described by
Oyaizu (1986) 2.5 mL of 0.2 M phosphate buffer (pH 6.6)
and 2.5 mL of K3Fe (CN)6 (1% w/v) are added to 1.0 mL of
sample dissolved in distilled water. The resulting mixture is
incubated at 50 C for 20 min, followed by the addition of
2.5 mL of Trichloro acetic acid (10% w/v). The mixture is
centrifuged at 3000 rpm for 10 min to collect the upper layer
of the solution (2.5 mL), mixed with distilled water (2.5 mL)
and 0.5 mL of FeCl3 (0.1%, w/v). The absorbance is then
measured at 700 nm against blank sample.
3.13. Phosphomolybdenum method
Total antioxidant capacity assay is a spectroscopic method for
the quantitative determination of antioxidant capacity,
through the formation of phosphomolybdenum complex.
The assay is based on the reduction of Mo (VI) to Mo (V)
by the sample analyte and subsequent formation of a green
phosphate Mo (V) complex at acidic pH. Total antioxidant
capacity can be calculated by the method described by Prieto
et al. (1999). 0.1 mL of sample (100 lg) solution is combined
with 1 mL of reagent (0.6 M sulfuric acid, 28 mM sodium
phosphate and 4 mM ammonium molybdate). The tube is
capped and incubated in a boiling water bath at 95 C for
90 min. After cooling the sample to room temperature, the
absorbance of the aqueous solution is measured at 695 nm
against blank in UV spectrophotometer. A typical blank solu-
tion contained 1 mL of reagent solution and the appropriate
volume of the same solvent used for the sample and it is incu-
bated under same conditions as rest of the sample. For samples
of unknown composition, antioxidant capacity can be
expressed as equivalents of a-tocopherol.
3.14. Ferric thiocyanate (FTC) method
This method can be exploited to determine the antioxidant
activity as illustrated by Kikuzaki et al. (1991). A mixture of
4 mg of sample (ﬁnal concentration of 0.02% w/v) in 4 mL
ethanol, 4.1 mL of 2.51% linoleic acid in ethanol, 8.0 mL of
0.02 M phosphate buffer (pH 7.0) and 3.9 mL of distilled water
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dark. 0.1 mL of the reaction mixture is transferred to a test
tube and, to it; 9.7 mL of 75% (v/v) aqueous ethanol, followed
by 0.1 mL of 30% aqueous ammonium thiocyanate and
0.1 mL of 0.02 M ferrous chloride in 3.5% hydrochloric acid
are added. Three minutes after the addition of ferrous chloride
to the reaction mixture, the absorbance of the resulting mix-
ture (red color) is measured at 500 nm every 24 h until the
absorbance of the control reached its maximum. Standard
antioxidant (ﬁnal concentration of 0.02% w/v) is used as posi-
tive control, and the mixture without the sample is used as the
negative control.
3.15. Thiobarbituric acid (TBA) method
TBA method, described by Ottolenghi (1959) is as follows: The
ﬁnal sample concentration of 0.02% w/v was used in this meth-
od. Two mL of 20% trichloroacetic acid and 2 mL of 0.67% of
thiobarbituric acid were added to 1 mL of sample solution.
The mixture was placed in a boiling water bath for 10 min
and then centrifuged after cooling at 3000 rpm for 20 min.
The absorbance activity of the supernatant was measured at
552 nm and recorded after it has reached its maximum.
3.16. DMPD (N,N-dimethyl-p-phenylene diamine
dihydrochloride) method
DMPD radical cation decolorization method has been devel-
oped for the measurement of the antioxidant activity in food
and biological samples. This assay is based on the reduction
of buffered solution of colored DMPD in acetate buffer and
ferric chloride. The procedure involves measurement of de-
crease in absorbance of DMPD in the presence of scavengers
at its absorption maximum of 505 nm. The activity was ex-
pressed as percentage reduction of DMPD.
Fogliano et al. (1999) obtained the radical by mixing 1 mL
of DMPD solution (200 mM), 0.4 mL of ferric chloride (III)
(0.05 M), and 100 mL of sodium acetate buffer solution at
0.1 M, modifying the pH to 5.25. The reactive mixture has
to be kept in darkness, under refrigeration, and at a low tem-
perature (4–5 C) .The reaction takes place when 50 lL of the
sample (a dilution of 1:10 in water) is added to 950 lL of the
DMPDÆ+ solution. Absorbance is measured after 10 min of
continuous stirring, which is the time taken to reach constant
decolorization values. The results are quantiﬁed in mM Trolox
on the relevant calibration curve.
3.17. b-carotene linoleic acid method/conjugated diene assay
This is one of the rapid method to screen antioxidants, which is
mainly based on the principle that linoleic acid, which is an
unsaturated fatty acid, gets oxidized by ‘‘Reactive Oxygen Spe-
cies’’ (ROS) produced by oxygenated water. The products
formed will initiate the b-carotene oxidation, which will lead
to discoloration. Antioxidants decrease the extent of discolor-
ation, which is measured at 434 nm and the activity is
measured.
The method as described by Kabouche et al. (2007): b-car-
otene (0.5 mg) in 1 mL of chloroform is added to 25 lL of lin-
oleic acid and 200 mg of tween-80 emulsiﬁed mixture.
Chloroform is evaporated at 40 C, 100 mL of distilled water
saturated with oxygen is slowly added to the residue and thesolution is vigorously agitated to form a stable emulsion. Four
mL of this mixture is added into the test tubes containing
200 lL of sample prepared in methanol at ﬁnal concentrations
(25, 50, 100, 200 and 400 lg/mL). As soon as the emulsiﬁed
solution is added to the tubes, zero time absorbance is mea-
sured at 470 nm. The tubes are incubated for 2 h at 50 C.
Vitamin C can be used as standard. Antioxidant activity is cal-
culated as percentage of inhibition (I%) relative to the control
using the following equation:
I% ¼ ½1 ðAsAs120Þ=AcAc120Þ
where As was initial absorbance, As120 was the absorbance of
the sample at 120 min, Ac was initial absorbance of negative
control and Ac120 was the absorbance of the negative control
at 120 min.
3.18. Xanthine oxidase method
The xanthine oxidase activity with xanthine as sub-substrate
can be measured spectrophotometrically, by the method of
Noro et al. (1983). The extract (500 lL of 0.1 mg/mL) and
allopurinol (100 lg/mL) (in methanol) are mixed with 1.3 mL
phosphate buffer (0.05 M, pH 7.5) and 0.2 mL of 0.2 units/
mL xanthine oxidase solution. After 10 min of incubation at
room temperature (25 C), 1.5 mL of 0.15 M xanthine sub-
strate solution is added to this mixture. The mixture is again
incubated for 30 min at room temperature (25 C) and then
the absorbance is measured at 293 nm using a spectrophotom-
eter against blank (0.5 mL methanol, 1.3 mL phosphate buffer,
0.2 mL xanthine oxidase). The solution of 0.5 mL methanol,
1.3 mL phosphate buffer, 0.2 mL xanthine oxidase and
1.5 mL xanthine substrate is used as a control. Percentage of
inhibition is calculated using the formula:
Percentage of inhibition ¼ ½1 ðAs=AcÞ  100
where As and Ac are the absorbance values of the test sample
and control, respectively.
3.19. Cupric ion reducing antioxidant capacity (CUPRAC)
method
The chromogenic oxidizing reagent of the developed CU-
PRAC method, that is, bis(neocuproine)copper(II) chloride
[Cu(II)-Nc], reacts with polyphenols [Ar(OH)n] in the manner.
2n CuðNcÞ2þ2 þArðOHÞn ¼ 2n CuðNcÞ2þ þArð¼ OÞnþ 2n Hþ
where the liberated protons may be buffered with the relatively
concentrated ammonium acetate buffer solution. In this reac-
tion, the reactive Ar-OH groups of polyphenols are oxidized
to the corresponding quinones and Cu (II)-Nc is reduced to
the highly colored Cu (I)-Nc chelate showing maximum
absorption at 450 nm.
According to Apak et al. (2008), 1 mL of 102 M of CuCl2,
1 mL of 7.5 · 103 M neocuproine and 1 M NH4CH3COO
solution are added into the glass test tube. Then, 400 lL of
freshly prepared standard solution is added and diluted to
the ﬁnal volume of 4.1 mL with deionized water. This proce-
dure is repeated for 400 lL, 300 lL, 200 lL, 100 lL and
50 lL additions of freshly prepared solutions of the sample.
The prepared solutions are mixed and incubated at room tem-
perature for 30 min. The absorbance at 450 nm is determined
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antioxidant capacity of compounds as Trolox equivalents
(TEAC values) by the CUPRAC method has been reported.
3.20. Metal chelating activity
Ferrozine can form a complex with a red color by forming che-
lates with Fe2+. This reaction is restricted in the presence of
other chelating agents and results in a decrease of the red color
of the ferrozine-Fe2+ complexes. Measurement of the color
reduction determines the chelating activity to compete with
ferrozine for the ferrous ions (Soler-Rivas et al., 2000). The
chelation of ferrous ions is estimated using the method of Dinis
et al. (1994). 0.1 mL of the extract is added to a solution of
0.5 mL ferrous chloride (0.2 mM). The reaction is started by
the addition of 0.2 mL of ferrozine (5 mM) and incubated at
room temperature for 10 min and then the absorbance is mea-
sured at 562 nm. EDTA or citric acid (Dinis et al., 1994) can be
used as a positive control.4. In vivo models
For all in vivomethods the samples that are to be tested are usu-
ally administered to the testing animals (mice, rats, etc.) at a
deﬁnite dosage regimen as described by the respective method.
After a speciﬁed period of time, the animals are usually sac-
riﬁced and blood or tissues are used for the assay.
4.1. Ferric reducing ability of plasma
It is one of the most rapid test and very useful for routine anal-
ysis (Umesh et al., 2010). The antioxidative activity is
estimated by measuring the increase in absorbance caused by
the formation of ferrous ions from FRAP reagent containing
TPTZ (2,4,6-tripyridyl-s-triazine) and FeCl2Æ6H2O. The absor-
bance is measured spectrophotometrically at 593 nm.
The method illustrated by Benzie and Strain (1996) involves
the use of blood samples that are collected from the rat retro-
orbital venous plexus into heparinized glass tubes at 0, 7 and
14 days of treatment. Three mL of freshly prepared and warm
(37 C) FRAP reagent [1 mL (10 mM) of 2,4,6 tripyridyl-s-tri-
azine (TPTZ) solution in 40 mM HCl, 1 mL 20 mM FeCl2Æ6-
H2O, 10 mL of 0.3 M acetate buffer (pH 3.6)] is mixed with
0.375 mL distilled water and 0.025 mL of test samples. The
absorbance of developed color in organic layer is measured
at 593 nm. The temperature is maintained at 37 C. The read-
ings at 180 s are selected for the calculation of FRAP values.
4.2. Reduced glutathione (GSH) estimation
GSH is an intra-cellular reductant and plays major role in
catalysis, metabolism and transport. It protects cells against
free radicals, peroxides and other toxic compounds (Sapakal
et al., 2008) Deﬁciency of GSH in the lens leads to cataract for-
mation. Glutathione also plays an important role in the kidney
and takes part in a transport system involved in the reabsorp-
tion of amino acids. The method illustrated by Ellman (1959)
can be used for determination of antioxidant activity. The
tissue homogenate (in 0.1 M phosphate buffer pH 7.4) is taken
and added with equal volume of 20% trichloroacetic acid
(TCA) containing 1 mM EDTA to precipitate the tissueproteins. The mixture is allowed to stand for 5 min prior to
centrifugation for 10 min at 2000 rpm. The supernatant
(200 lL) is then transferred to a new set of test tubes and
added with 1.8 mL of the Ellman’s reagent (5,50-dithiobis-2-
nitrobenzoic acid (0.1 mM) prepared in 0.3 M phosphate buf-
fer with 1% of sodium citrate solution). Then all the test tubes
are made up to the volume of 2 mL. After completion of the
total reaction, solutions are measured at 412 nm against blank.
Absorbance values were compared with a standard curve gen-
erated from known GSH.
4.3. Glutathione peroxidase (GSHPx) estimation
GSHPX is a seleno-enzyme two third of which (in liver) is
present in the cytosol and one third in the mitochondria. It cat-
alyzes the reaction of hydroperoxides with reduced glutathione
to form glutathione disulﬁde (GSSG) and the reduction prod-
uct of hydroperoxide. GSHPx is found throughout the tissues,
being present as four different isoenzymes, cellular glutathione
peroxidase, extracellular glutathione peroxidase, phospholipid
hydroperoxide glutathione peroxidase and gastrointestinal glu-
tathione peroxidase. GSHPx measurement is considered in
particular with patients who are under oxidative stress for
any reason; low activity of this enzyme is one of the early
consequences of a disturbance of the prooxidant/antioxidant
balance (Paglia and Valentin, 1967; Yang et al., 1984).
According to Wood (1970), Cytosolic GPx is assayed via a
3-mL cuvette containing 2.0 mL of 75 mM/L phosphate buf-
fer, pH 7.0. The following solutions are then added: 50 lL of
60 mM/L glutathione reductase solution (30 U/mL), 50 lL of
0.12 M/L NaN3, 0.10 of 0.15 mM/L Na2EDTA, 100 lL
of 3.0 mM/L NADPH, and 100 lL of cytosolic fraction ob-
tained after centrifugation at 20,000 g for 25 min. Water is
added to make a total volume of 2.9 mL. The reaction is
started by the addition of 100 lL of 7.5 mM/L H2O2, and
the conversion of NADPH to NADP is monitored by a contin-
uous recording of the change of absorbance at 340 nm at 1 min
interval for 5 min. Enzyme activity of GSHPx was expressed in
terms of mg of proteins.
4.4. Glutathione-S-transferase (GSt)
Glutathione-S-transferase is thought to play a physiological
role in initiating the detoxication of potential alkylating
agents, including pharmacologically active compounds. These
enzymes catalyze the reaction of such compounds with the -
SH group of glutathione, thereby neutralizing their electro-
philic sites and rendering the products more water-soluble.
The method can be used as described by Jocelyn (1972). The
reaction mixture (1 mL) consisted of 0.1 N potassium
phosphate (pH 6.5), 1 nM/L GSt, 1 M/L l-chloro-2, 4-dinitro-
benzene as substrate and a suitable amount of cytosol
(6 mg protein/mL). The reaction mixture is incubated at
37 C for 5 min and the reaction is initiated by the addition
of the substrate. The increase in absorbance at 340 nm was
measured spectrophotometrically.
4.5. Superoxide dismutase (SOD) method
This method is well described by Mccord and Fridovich (1969)
and can be applied for determination of antioxidant activity of
a sample. It is estimated in the erythrocyte lysate prepared
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of Tris–HCl buffer (pH 8.2), 30 mM EDTA and 2 mM of
pyrogallol are added. An increase in absorbance is recorded
at 420 nm for 3 min by spectrophotometer. One unit of enzyme
activity is 50% inhibition of the rate of autooxidation of pyro-
gallol as determined by change in absorbance/min at 420 nm.
The activity of SOD is expressed as units/mg protein.
4.6. Catalase (CAT)
Catalase activity can be determined in erythrocyte lysate using
Aebi’s method (Aebi, 1984). Fifty microliter of the lysate is
added to a cuvette containing 2 mL of phosphate buffer
(pH 7.0) and 1 mL of 30 mM H2O2. Catalase activity is mea-
sured at 240 nm for 1 min using spectrophotometer. The molar
extinction coefﬁcient of H2O2, 43.6 M cm
1 was used to deter-
mine the catalase activity. One unit of activity is equal to
1 mmol of H2O2 degraded per minute and is expressed as units
per milligram of protein.
4.7. c-Glutamyl transpeptidase activity (GGT) assay
According to Singhal et al. (1982), the serum sample is added
to a substrate solution containing glycylglycine, MgCl2 and g-
Glutamyl-p-nitroanilide in 0.05 M tris (free base), pH 8.2. The
mixture is incubated at 37 C for 1 min and the absorbance
read at 405 nm at 1 m interval for 5 m. The activity of GGT
is calculated from the absorbance values.
4.8. Glutathione reductase (GR) assay
The ubiquitous tripeptide glutathione (GSH), which is the
most abundant low molecular weight thiol in almost all cells,
is involved in a wide range of enzymatic reactions. A major
function of GSH is to serve as a reductant in oxidation–reduc-
tion processes; a function resulting in the formation of gluta-
thione disulﬁde (GSSG). A heat labile system capable of
reducing GSSG was discovered in liver. The enzyme directly
involved in reduction of GSSG.
The method illustrated by Kakkar et al. (1984) is as follows:
Livers (about 400 g) are obtained from killed rats (200–250 g).
The livers are cut into small pieces and homogenized in 9 mL
of 0.25 M ice-cold sucrose per g of rat liver in a blender. The
homogenate is centrifuged for 45 min at 14,000 rpm. The pel-
lets are suspended in a small volume of 0.25 M sucrose and
centrifuged. The supernatants are combined with the previous
centrifugate. The pooled material is adjusted to pH 5.5 with
cold 0.2 M acetic acid and centrifuged again for 45 min at
14,000 rpm. The rate of oxidation of NADPH by GSSG at
30 C is used as a standard measure of enzymatic activity.
The reaction system of 1 mL contained: 1.0 mM GSSG,
0.1 mM NADPH, 0.5 mM EDTA, 0.10 M sodium phosphate
buffer (pH 7.6), and a suitable amount of the glutathione
reductase sample to give a change in absorbance of 0.05–
0.03/min. The oxidation of 1 lM of NADPH/min under these
conditions is used as a unit of glutathione reductase activity.
The speciﬁc activity is expressed as units per mg of protein.
4.9. Lipid peroxidation (LPO) assay
LPO is an autocatalytic process, which is a common conse-
quence of cell death. This process may cause peroxidativetissue damage in inﬂammation, cancer and toxicity of xenobi-
otics and aging. Malondialdehyde (MDA) is one of the end
products in the lipid peroxidation process. Malondialdehyde
(MDA) is formed during oxidative degeneration as a product
of free oxygen radicals, which is accepted as an indicator of li-
pid peroxidation.
This method described by Okhawa (1979) is as follows: The
tissues are homogenized in 0.1 M buffer pH 7.4 with a Teﬂon-
glass homogenizer. LPO in this homogenate is determined by
measuring the amounts of malondialdehyde (MDA) produced
primarily. Tissue homogenate (0.2 mL), 0.2 mL of 8.1% so-
dium dodecyl sulfate (SDS), 1.5 mL of 20% acetic acid and
1.5 mL of 8% TBA are added. The volume of the mixture is
made up to 4 mL with distilled water and then heated at
95 C on a water bath for 60 min using glass balls as condenser.
After incubation the tubes are cooled to room temperature and
ﬁnal volume was made to 5 mL in each tube. Five mL of buta-
nol: pyridine (15:1) mixture is added and the contents are vor-
texed thoroughly for 2 min. After centrifugation at 3000 rpm
for 10 min, the upper organic layer is taken and its OD is taken
at 532 nm against an appropriate blank without the sample.
The levels of lipid peroxides can be expressed as n moles of thio-
barbituric acid reactive substances (TBARS)/mg protein using
an extinction coefﬁcient of 1.56 · 105 ML cm1.4.10. LDL assay
The isolated LDL is washed and dialyzed against 150 mmol/L
NaCl and 1 mmol/L Na2EDTA (pH 7.4) at 4 C. The LDL is
then sterilized by ﬁltration (0.45 lM), kept under nitrogen in
the dark at 4 C. LDL (100 lg of protein/mL) is incubated
for 10 min at room temperature with samples. Then, 5 lmol/
L of CuSO4 is added, and the tubes are incubated for 2 h at
37 C. Cu2+-induced oxidation is terminated by the addition
of butylated hydroxytoluene (BHT, 10 lM). At the end of the
incubation, the extent of LDL oxidation is determined by mea-
suring the generated amount of lipid peroxides and also by the
thiobarbituric acid reactive substances (TBARS) assay at
532 nm, using malondialdehyde (MDA) for the standard curve
as described by Buege and Aust, 1978; El-Saadani et al., 1989.5. Results and discussion
In addition to compilation of various methods related to eval-
uation of antioxidant activity, it was our interest to see the fre-
quency of each method of a given number of citations being
used. The results of the said frequency analysis for in vitro
and in vivo methods are shown in Figs. 1 and 2, respectively.
It is clear from Fig. 1 that four in vitro methods were most fre-
quently used and these were in order of decreasing frequency:
DPPH> Hydroxyl radical scavenging > SOD> b-carotene
linolate. Out of all the in vitro methods, DPPH is the most
easy, simple and reasonably costly method and hence it might
have been used mostly for the antioxidant activity evaluation
of a sample. If one looks into Fig. 2, it immediately appears
that the frequency of use is higher for LPO assay and it was
followed by CAT and GSHPx. Lipid is a major component
of cell membrane and thus its peroxidation almost directly
co-relates peroxidative damage of cell in vivo and hence it
might have been found to have the highest frequency in vivo
antioxidant activity assay.
Figure 1 Frequency of commonly used In vitro methods.
Figure 2 Frequency of commonly used In vivo methods.
Figure 3 Commonly used extracting solvents for antioxidant
study.
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extraction of a material to evaluate its antioxidant property.
It is evident from the ﬁgure that four solvents are prominently
being used for the extraction purpose in relation to the stated
experiment. These solvents are ethanol, water, methanol and
aqueous ethanol. Ethanol, methanol and water have good
polarity and hence are used favorably to extract polar com-
pounds such as phenolic compounds and ﬂavonoids which are
believed to be effective antioxidants. Ethanol being organic
and nontoxicmight have the highest frequency of use for extrac-
tion purpose. Water needs a different step of freeze drying toremove it from the extract after extraction. Toxicity of metha-
nol limits its use in some extraction and subsequent experiment.
Non-polar solvents such as ether and low polarity solvents such
as chloroform, ester, acetone etc. have been used in speciﬁc
cases and their availability also limits their use in the experiment
and hence their frequency of use was found very low.6. Conclusion
This review article is focused on in vitro and in vivo methods of
antioxidant evaluation. It was prepared based on plenty liter-
ature search. Presently, 19 in vitro and 10 in vivo methods
are being used for antioxidant evaluation purpose. DPPH
method is the most frequently used one for in vitro antioxidant
activity evaluation while LPO was found as the mostly used
in vivo antioxidant assay. Ethanol extract was found with the
highest frequency for antioxidant study. This article will be a
comprehensive ready reference for those who are interested
on antioxidant study.References
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